Sequenom, Inc., a life sciences company, provides genetic analysis solutions in the United States and internationally. It operates through two segments, Molecular Diagnostics and Genetic Analysis. The Molecular Diagnostics segment researches, develops, and commercializes various noninvasive molecular diagnostic tests for prenatal genetic disorders and diseases; women’s health related disorders and diseases; and ophthalmologic, oncologic, and other medical conditions, such as autoimmunity and neurology. The Genetic Analysis segment offers Mass ARRAY system, a nucleic acid analysis research-use only system that measures genetic target material and variations; and research use only iPLEX multiplexing assay, which permits multiplexed single nucleotide polymorphism (SNP) and somatic mutation analysis. Its MassARRAY systems are used in a range of DNA/RNA analysis applications, including SNP, genotyping, detection of mutations, analysis of copy number variants, and other structural genome variations, as well as in quantitative gene expression analysis, quantitative DNA methylation analysis, comparative sequence analysis of haploid organisms, SNP discovery, and oligonucleotide quality control. This segment also provides contract research services to clinical research laboratories, bioagriculture, biotechnology and pharmaceutical companies, academic institutions, and government agencies. The company was founded in 1994 and is headquartered in San Diego, California.

Key Statistics